Cargando…
Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
SIMPLE SUMMARY: Chondrosarcomas develop chemoresistance to standard anticancer drugs, making it difficult to control unresectable or metastatic chondrosarcomas. To improve the clinical outcomes of chondrosarcoma, new treatment approaches, such as molecule-targeting agents and immunotherapy, are need...
Autores principales: | Miwa, Shinji, Yamamoto, Norio, Hayashi, Katsuhiro, Takeuchi, Akihiko, Igarashi, Kentaro, Tsuchiya, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834928/ https://www.ncbi.nlm.nih.gov/pubmed/35163019 http://dx.doi.org/10.3390/ijms23031096 |
Ejemplares similares
-
Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019) -
Recent Advances and Challenges in the Treatment of Rhabdomyosarcoma
por: Miwa, Shinji, et al.
Publicado: (2020) -
Current and Emerging Targets in Immunotherapy for Osteosarcoma
por: Miwa, Shinji, et al.
Publicado: (2019) -
Surgical Site Infection after Bone Tumor Surgery: Risk Factors and New Preventive Techniques
por: Miwa, Shinji, et al.
Publicado: (2022) -
Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report
por: Yonezawa, Hirotaka, et al.
Publicado: (2022)